Outcomes for SAD markers | Unstandardized β | Standardized β | 95% CI | P value |
---|---|---|---|---|
CT | Â | Â | Â | Â |
 LAA−950, % | 1.03 | 0.13 | 0.63, 1.43 |  < 0.001 |
 LAA−856, % | 6.86 | 0.26 | 5.56, 8.16 |  < 0.001 |
 RV, L | 0.17 | 0.12 | 0.10, 0.23 |  < 0.001 |
 TLC, L | − 0.17 | − 0.12 | − 0.24, − 0.10 |  < 0.001 |
IOS | Â | Â | Â | Â |
 R5, Ka/L/s | 0.02 | 0.10 | 0.01, 0.02 |  < 0.001 |
 R20, Ka/L/s | 0.00 | − 0.001 | − 0.01, 0.004 | 0.964 |
 R5–R20, Ka/L/s | 0.02 | 0.15 | 0.01, 0.02 |  < 0.001 |
 X5, Ka/L/s | − 0.02 | − 0.16 | − 0.02, − 0.01 |  < 0.001 |
 AX, Ka/L | 0.21 | 0.16 | 0.14, 0.28 |  < 0.001 |
 Fres, Hz | 1.60 | 0.21 | 1.18, 2.03 |  < 0.001 |
Postbronchodilator | Â | Â | Â | Â |
 MMEF, %predicted | − 5.32 | − 0.26 | − 6.40, − 4.24 |  < 0.001 |
 FEF50, %predicted | − 6.77 | − 0.27 | − 8.08, − 5.46 |  < 0.001 |
 FEF75, %predicted | − 2.40 | − 0.14 | − 3.33, − 1.46 |  < 0.001 |